![]() Taiwan Liposome Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). | ![]() Disc Medicine Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
| |||
Founding Date | Founding Date 2022 | Founding Date 1997 | Founding Date 2019 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Berkeley, US HQ Chippendale, AU | Locations Taipei, TW HQ 港区, JP Leiden, NL South San Francisco, US | Locations Paris, FR HQ Paris, FR | Locations Watertown, US HQ |
Employees | Employees 167% increase | Employees 1652% decrease | Employees 783% increase | Employees 15585% increase |
Financial | ||||
Net income | Net income N/A | Net income (NT$983.3m) (FY, 2020) | Net income N/A | Net income ($212.2m) (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round $ 12m (over 2 years ago) | Latest funding round N/A | Latest funding round $ 1.1m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 12m | Total funding raised N/A | Total funding raised $ 1.1m | Total funding raised $ 50m |

Taiwan Liposome is a pharmaceutical company dedicated to the development and commercialization of novel nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs).
View company
Aqemia is a company that develops molecule matching technology.
View company
Disc Medicine (formerly known as Gemini Therapeutics) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for patients suffering from hematologic diseases.
View company